Review for disease of the year: Epidemiology of juvenile idiopathic arthritis and its associated uveitis: The probable risk factors

Ocular Immunology and Inflammation

Volumn 21, Issue 3, 2013, Pages 180-191

  Heiligenhaus, Arnd ^a   Heinz, Carsten ^a   Edelsten, Clive ^b,c   Kotaniemi, Kaisu ^d   Minden, Kirsten ^e  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b IPSWICH HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Complications; Epidemiology; Juvenile idiopathic arthritis; Risk factors; Uveitis; Visual outcome

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

CATARACT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; EYE INJURY; FOLLOW UP; GENETIC RISK; GLAUCOMA; GROWTH DISORDER; HIGH RISK PATIENT; HIP INJURY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR HYPERTENSION; JUVENILE RHEUMATOID ARTHRITIS; KERATOPATHY; LUNG TUBERCULOSIS; MUSCLE ATROPHY; RETINA MACULA EDEMA; REVIEW; TEMPOROMANDIBULAR JOINT DISORDER; UVEITIS; VISUAL IMPAIRMENT; WRIST INJURY;

AGE FACTORS; AGE OF ONSET; ARTHRITIS, JUVENILE; CHILD; HUMANS; MORBIDITY; RISK FACTORS; UVEITIS; WORLD HEALTH;

EID: 84878442557     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2013.791701     Document Type: Review

References (99)

1. Petty RE, Southwood TR, Manners P. International league of associations for rheumatology. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-392. (Pubitemid 38160763)
2. Berntson L, Andersson Gäre B, Fasth A, et al, Nordic Study Group. Incidence of juvenile idiopathic arthritis in the Nordic countries: a population-based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30:2275-2282. (Pubitemid 37221864)
3. Danner S, Sordet C, Terzic J, et al. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol. 2006;33: 1377-1381. (Pubitemid 44025153)
4. Hanova P, Pavelka K, Dostal C, et al. Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003. Clin Exp Rheumatol. 2006;24:499-507. (Pubitemid 44913611)
5. Pruunsild C, Uibo K, Liivamägi H, et al. Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand J Rheumatol. 2007;36:7-13 (Pubitemid 46578065)
6. Riise ØR, Handeland KS, Cvancarova M, et al. Incidence and characteristics of arthritis in Norwegian children: a population-based study. Pediatrics. 2008;121:e299-e306. (Pubitemid 351198435)
7. Solau-Gervais E, Robin C, Gambert C, et al. Prevalence and distribution of juvenile idiopathic arthritis in a region of Western France. Joint Bone Spine. 2010;77:47-49.
8. Modesto C, Antón J, Rodriguez B, et al. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol. 2010;39:472-479.
9. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis: why does it vary so much? J Rheumatol. 2002;29: 1520-1530. (Pubitemid 34755622)
10. Kaipiainen-Seppänen O, Savolainen A. Changes in the incidence of juvenile rheumatoid arthritis in Finland. Rheumatology (Oxford). 2001;40:928-932.
11. Pruunsild C, Uibo K, Liivamägi H, et al. Prevalence and short-term outcome of juvenile idiopathic arthritis: a population-based study in Estonia. Clin Exp Rheumatol. 2007;25:649-653. (Pubitemid 47455477)
12. Ellis JA, Munro JE, Ponsonby AL. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology (Oxford). 2010;49:411-425.
13. Saurenmann RK, Rose JB, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Ethnicity as a risk factor. Arthritis Rheum. 2007;56: 1974-1984. (Pubitemid 47110396)
14. Kurahara D, Tokuda A, Grandinetti A, et al. Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population. J Rheumatol. 2002;29:379-383. (Pubitemid 34118791)
15. Nordal E, Zak M, Aalto K, et al; Nordic Study Group of Pediatric Rheumatology. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63: 2809-2818.
16. Oen K, Duffy CM, Tse SM, et al. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care Res (Hoboken). 2010;62:527-536.
17. Hyrich KL, Lal SD, Foster HE, et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford). 2010;49:116-122.
18. Kunjir V, Venugopalan A, Chopra A. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol. 2010;37: 1756-1762.
19. Shen CC, Yeh KW, Ou LS, et al. Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan. J Microbiol Immunol Infect. 2012 Jun 21. pii: S1684-1182(12)00044-8.
20. Weakley K, Scott C, Esser M. Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa. Pediatr Rheumatol Online J. 2012;10:35.
21. Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2008;6:11.
22. Hollenbach JA, Thompson SD, Bugawan TL, et al. Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. Arthritis Rheum. 2010;62: 1781-1791.
23. Thompson SD, Marion MC, Sudman M, et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum. 2012;64:2781-2791.
24. Prahalad S, Shear ES, Thompson SD, et al. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46:1851-1856. (Pubitemid 34774517)
25. Magnani A, Pistorio A, Magni-Manzoni S, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36:628-634.
26. Viola S, Felici E, Magni-Manzoni S, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:2092-2102. (Pubitemid 40994332)
27. Russo RA, Katsicas MM. Global damage in systemic juvenile idiopathic arthritis: preliminary early predictors. J Rheumatol. 2008;35:1151-1156. (Pubitemid 351813165)
28. Flato B, Lien G, Smerdel A, et al. Prognostic factors in juvenile rheumatoid arthritis; a case control study revealing early predictors and outcome after 14.9 years. J Rheumatol. 2003;30:386-393. (Pubitemid 36152609)
29. Oen K, Reed M, Malleson PN, et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J Rheumatol. 2003;30:832-840. (Pubitemid 36402781)
30. Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum. 2003;48:767-775. (Pubitemid 36302014)
31. Minden K, Niewerth M, Zink A, et al. Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO. Rheumatology (Oxford). 2012;51: 1407-1415.
32. Oen K, Malleson PN, Cabral DA, et al. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol. 2002;29:1989-1999. (Pubitemid 34988711)
33. Bernatzky S, Duffy C, Malleson P, et al. Economic impact of juvenile idiopathic arthritis. Arthritis Rheum. 2007;57: 44-48.
34. Haapasaari J, Kautiainen HJ, Isomäki HA, Hakala M. Etanercept does not essentially increase the total costs of the treatment of refractory juvenile idiopathic arthritis. J Rheumatol. 2004;31:2286-2289. (Pubitemid 39453252)
35. Minden K, Niewerth M, Listing J, et al. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis. 2004;63:836-842. (Pubitemid 38850456)
36. Adib N, Silman A, Thomson W. Outcome following onset of juvenile idiopathic inflammatory arthritis: II. predictors of outcome in juvenile arthritis. Rheumatology (Oxford). 2005;44:1002-1007. (Pubitemid 41487172)
37. Gritz DC, Wong IG. Incidence and prevalence of uveitis in northern California; the Northern California epidemiology of uveitis study. Ophthalmology. 2004;111:491-500. (Pubitemid 38293104)
38. de Smet MD, Taylor SRJ, Bodaghi B, et al. Understanding uveitis: The impact of research on visual outcomes. Prog Retin Eye Res. 2011;30:452-470.
39. Kanski JJ. Juvenile arthritis and uveitis. Surv Ophhalmol. 1990;34:253-267. (Pubitemid 20098164)
40. Kimura SJ, Hogan MJ, Thygeson P. Uveitis in children. Arch Ophthalmol. 1954;51:80-84.
41. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Arch Ophthalmol. 1962;68:100-112.
42. Paivonsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000;78:84-88. (Pubitemid 30095319)
43. Edelsten C, Reddy MA, Stanford MR, et al. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135:676-680. (Pubitemid 36457974)
44. Carvounis PE, Herman DC, Cha S, et al. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefe's Arch Clin Exp Ophthalmol. 2006;244:281-290.
45. Sherry DD, Mellins ED, Wedgwood RJ. Decreasing severity of chronic uveitis in Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544-1551.
46. Bolt JB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and long-term outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol. 2008;35:703-706. (Pubitemid 351500070)
47. Heiligenhaus A, Niewerth M, Ganser G, et al. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007;46:1015-1019. (Pubitemid 47062514)
48. Aggarwal A, Misra RN. Juvenile rheumatoid arthritis in India-rarity of antinuclear antibody and uveitis. Indian J Pediatr. 1996;63:301-304. (Pubitemid 126552052)
49. McGill NW, Gow PJ. Juvenile rheumatoid arthritis in Auckland: a long term follow-up study with particular reference to uveitis. Aust N Z J Med. 1987;17:305-308.
50. Arguedas O, Fasth A, Andersson-Gäre B, Porras O. Juvenile chronic arthritis in urban San José, Costa Rica: a 2 year prospective study. J Rheumatol. 1998;25:1844-1850. (Pubitemid 28439283)
51. Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol. 1997;24:1826-1829. (Pubitemid 27394525)
52. Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A. A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1999;17:119-122. (Pubitemid 29099901)
53. Kunnamo I, Kallio P, Pelkonen P, et al. Incidence of arthritis in urban Finnish children. A prospective study. Arthritis Rheum. 1986;29:1232-1238. (Pubitemid 16005513)
54. Kotaniemi K, Kautiainen H, Karma A, et al. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis. A prospective study. Ophthalmology. 2001;108:2071-2075. (Pubitemid 33032781)
55. Saurenmann RK, Levin AV, Feldman BM, et al. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum. 2010;62: 1824-1828.
56. Säilä H, Kotaniemi K, Savolainen A, et al. Uveitis in sibling pairs with juvenile idiopathic arthritis. Rheumatology. 2001; 40:221-224.
57. Julián K, Terrada C, Quartier P, et al. Uveitis related to juvenile idiopathic arthritis: familial cases and possible genetic implication in the pathogenesis. Ocul Immunol Inflamm. 2010;18:172-177.
58. Grassi A, Corona F, Casellato A, et al. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease. J Rheumatol. 2007;34: 1139-1145. (Pubitemid 46774862)
59. Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M, et al. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur J Immunogenet. 1999;26:299-310. (Pubitemid 29364028)
60. Zeggini E, Packham J, Donn R, et al. Association of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets. Rheumatology. 2006;45:972-974. (Pubitemid 44283051)
61. Ploski R, Vinje O, Rønningen KS, et al. HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease. Arthritis Rheum. 1993;36:465-472. (Pubitemid 23104033)
62. McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 1995;38:221-228.
63. Zulian F, Martini G, Falcini F, et al. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol. 2002;29:2446-2453. (Pubitemid 35266041)
64. Chylack LT. The ocular manifestations of juvenile rheumatoid arthritis. Arthritis Rheum. 1977;20:217-223.
65. Kanski JJ. Anterior uveitis in juvenile rheumatoid arthritis. Arch Ophthalmol. 1977;95:1794-1797. (Pubitemid 8205924)
66. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcome prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104: 236-244. (Pubitemid 27088098)
67. Chia A, Lee V, Graham EM, et al. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;35: 757-762. (Pubitemid 36677391)
68. Tugal-Tutkun I, Havrlikova K, Power WJ, et al. Changing patterns in uveitis in childhood. Ophthalmology. 1996;103: 375-383.
69. Chalom EC, Goldsmith DP, Koehler MA. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997;24: 2031-2034. (Pubitemid 27431939)
70. Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111: 2299-2304.
71. Cabral DA, Petty RE, Malleson PN. Visual prognosis in children with chronic anterior uveitis and arthritis. J Rheumatol. 1994;21:2370-2375.
72. De Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879-884. (Pubitemid 36765255)
73. Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, et al. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis. 2005;64: 871-874. (Pubitemid 40733911)
74. Mingels A, Hudde T, Heiligenhaus A. Vision threatening complications in childhood uveitis. Ophthalmologe. 2005; 102:477-484. (Pubitemid 40767779)
75. Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143: 840-846.
76. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987;94:1242-1248. (Pubitemid 17149332)
77. Edelsten C, Lee V, Bentley CR, et al. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002; 86:51-56. (Pubitemid 34074885)
78. Rosenberg AM, Oen KG. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 1986;29:797-800. (Pubitemid 16094159)
79. Holland GN, Denove CS, Yu F, et al. Chronic anterior uveitis in children; clinical characteristics and complications. Am J Ophthalmol. 2009;147:667-678.
80. Kalinina Ayuso V, ten Cate HAT, van der Does P, et al. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010; 149:987-993.
81. Kalinina Ayuso V, ten Cate HAT, van der Does P, et al. Male gender as a risk factor for complications in uve-itis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149:994-999.
82. Hoeve M, Kalinina Ayuso V, Schalij-Delfos NE, et al. The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Br J Ophthalmol. 2012;96:852-856.
83. Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis (JIA). Am J Ophthalmol. 2007;143: 647-655.
84. Sabri K, Saurenmann RT, Silverman ED, et al. Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS. 2008;12:539-545.
85. Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcome and prognosis. Can J Ophthalmol. 2004;39:614-620. (Pubitemid 39472081)
86. Camuglia JE, Whitford CL, Hall AJ. Juvenile idiopathic arthritis associated uveitis in adults: a case series. Ocul Immunol Inflamm. 2009;17:330-334.
87. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509-516. (Pubitemid 41224845)
88. Brewer EJ Jr, Bass J, Baum J et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum. 1977;20:195-199.
89. Fantini F. Rheumatoid arthritis in children and related forms. Updating of nomenclature, clinical manifestations and therapy, with reference to the EULAR/WHO workshop on the care of rheumatic children. Oslo, March 1977. Reumatismo. 1977;29:7-32.
90. Heiligenhaus A, Foeldvari I, Edelsten C, et al. Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res. 2012;64:1365-1372.
91. Kump LI, Cervantes-Castaneda RA, Androudi SN, et al. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112:1287-1292. (Pubitemid 40916939)
92. Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009; 116:1544-1551.
93. Kazdan JJ, McCulloch CJ, Crawford JS. Uveitis in children. Can Med Assoc J. 1967;96:385-391.
94. Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984;91: 1247-1252.
95. Pivetti-Pezzi P. Uveitis in children. Eur J Ophthalmol. 1996; 6:293-298. (Pubitemid 26346058)
96. Soylu M, Ozdemir G, Anli A. Pediatric uveitis in Southern Turkey. Ocul Immunol Inflamm. 1997;5:197-202. (Pubitemid 27445569)
97. Kadayifcilar S, Eldern B, Turner B. Uveitis in childhood. J Pediatr Ophthalmol Strabismus. 2003;40:335-340. (Pubitemid 37448904)
98. BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005;89:444-448. (Pubitemid 40469963)
99. Khairallah M, Attia S, Zaouali S, et al. Pattern of childhood onset uveitis in a referral center in Tunisia, North Africa. Ocul Immunol Inflamm. 2006;14: 225-231. (Pubitemid 44266800)